VIEWRAY TECHNOLOGIES INC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.9M
Doctors Paid
304
Transactions
1,509
2022 Total
$1.8M
Payment Breakdown by Category
Research$4.0M (69.0%)
Consulting$760,528 (13.0%)
Travel$249,663 (4.3%)
Royalty/License$130,321 (2.2%)
Food & Beverage$74,255 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.0M | 204 | 69.0% |
| Consulting Fee | $760,528 | 118 | 13.0% |
| Current or prospective ownership or investment interest | $307,544 | 1 | 5.3% |
| Travel and Lodging | $249,663 | 362 | 4.3% |
| Honoraria | $148,194 | 115 | 2.5% |
| Royalty or License | $130,321 | 2 | 2.2% |
| Food and Beverage | $74,255 | 650 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,275 | 37 | 0.8% |
| Education | $46,090 | 6 | 0.8% |
| Space rental or facility fees (teaching hospital only) | $41,000 | 12 | 0.7% |
| Charitable Contribution | $10,000 | 1 | 0.2% |
| Gift | $189.41 | 1 | 0.0% |
Payments by Type
Research
$4.0M
202 transactions
General
$1.8M
1,305 transactions
Ownership
$0
2 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Prospective Phase II Study of Stereotactic MR-guided on-table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Inoperable Locally Advanced Pancreatic Cancer. | $1.0M | 3 | 41 |
| SMART Study - Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer | $318,103 | 0 | 43 |
| MIRAGE, HEATWAVE, & EXCALIBUR | $250,725 | 0 | 1 |
| Prospective Phase II Study of Stereotactic MR-guided ontable Adaptive Radiation Therapy for Patients with Borderline or Inoperable Locally Advanced Pancreatic (SMART Study) | $243,199 | 0 | 45 |
| Stereotactic MR-guided Adaptive Radiation Therapy (SMART) for Cervical Cancer and Stereotactic MR guided Adaptive Radiotherapy (SMART) in Adjuvant Management of the Post-Operative Female Pelvis | $200,000 | 0 | 1 |
| A Feasibility Study of Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction for Inoperable Primary or Metastatic Carcinoma (SMART ONE) | $195,000 | 0 | 2 |
| Northwestern IIS (multiple projects funded) | $175,000 | 0 | 1 |
| FORT Prostate Reasearch Study | $119,687 | 0 | 1 |
| Phase II Study of LUNG STereotactic Adaptive Ablative Radiotherapy for Central and Ultracentral Tumors. (LUNG STAAR) | $100,000 | 0 | 1 |
| Preoperative MR-Guided Radiation Therapy to Improve Oncologic Outcomes in Gastric Cancer | $75,000 | 0 | 1 |
| CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study | $75,000 | 0 | 1 |
| Enhancing the efficacy of PDAC directed SBRT by prevention of ADAM10 driven cytotoxic resistance and metastasis | $68,000 | 0 | 1 |
| H/N Research Project | $65,340 | 0 | 1 |
| Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer in 4 Weeks v. 2 Weeks (SHORTER) | $63,735 | 0 | 2 |
| Deep learning application in real-time automatic tumor detection andtracking for MR-guided adaptive prostate SBRT | $61,303 | 0 | 1 |
| SHORTER Study | $60,533 | 0 | 1 |
| Nanobody Immune-guided Radiation Therapy | $60,000 | 0 | 2 |
| MR/Radiotherapy researh fellowship | $60,000 | 0 | 1 |
| Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma | $58,743 | 0 | 2 |
| Prospective Study of Stereotactic Body Radio Therapy (SBRT) Following Radical Prostatectomy | $56,549 | 0 | 1 |
| Towards anatomically and functionally guided adaptive radiotherpy ofcervical tumors | $53,426 | 0 | 1 |
| Deep Learning Applications for the ViewRay MR-LINAC | $53,426 | 0 | 1 |
| Low field perfusion and diffusion imaging via selfsupervised deeptransform learning | $53,425 | 0 | 1 |
| This study seeks to improve an area of clinical need, RT boost in poorly defined cavities, with a technical innovation, MRgRT on the MRIdian. | $50,807 | 0 | 1 |
| Evaluation of efficiency gains and the patient experience utilizing an in-bore visual feedback system for management of MR-guided adaptive radiotherapy | $49,600 | 0 | 1 |
| Feasibility and efficacy of neoadjuvant MR-guided radiotherapy with concurrent carboplatin/paclitaxel in locally advanced gastric cancer) | $43,594 | 0 | 4 |
| MRI Guided Cavity Radiation in Resected Brain Metastasis | $43,258 | 0 | 4 |
| SMARTer: Development of an Eductional Resource to Faciliate Online Adaptive Radiotherapy | $42,651 | 0 | 1 |
| Feasibility of ViewRay MRIdian MRI-LINAC for spine stereotactic body radiation therapy (SBRT) | $37,440 | 0 | 4 |
| High-Precision Cardiac Motion Modeling and Gating Using the MRIdian System - Healthy Volunteer Study | $31,184 | 0 | 2 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Radiation Oncology | $849,576 | 229 | $3,710 |
| General Practice | $312,435 | 2 | $156,218 |
| Addiction Medicine | $12,028 | 1 | $12,028 |
| Internal Medicine | $8,090 | 12 | $674.21 |
| Hematology & Oncology | $5,884 | 2 | $2,942 |
| Diagnostic Radiology | $4,543 | 6 | $757.11 |
| Neurological Surgery | $2,462 | 3 | $820.70 |
| Family Medicine | $1,984 | 3 | $661.23 |
| Student in an Organized Health Care Education/Training Program | $1,714 | 8 | $214.22 |
| Medical Oncology | $1,679 | 1 | $1,679 |
| Ophthalmology | $1,000 | 1 | $1,000 |
| Therapeutic Radiology | $863.94 | 3 | $287.98 |
| Emergency Medicine | $746.56 | 2 | $373.28 |
| Specialist | $662.15 | 8 | $82.77 |
| Maternal & Fetal Medicine | $512.38 | 1 | $512.38 |
| Physician Assistant | $419.20 | 4 | $104.80 |
| Surgery | $274.42 | 4 | $68.61 |
| Pediatrics | $211.55 | 1 | $211.55 |
| Medical | $172.91 | 1 | $172.91 |
| Family | $152.96 | 3 | $50.99 |
| Thoracic Surgery (Cardiothoracic Vascular Surgery) | $149.66 | 1 | $149.66 |
| Adult Health | $133.72 | 1 | $133.72 |
| Colon & Rectal Surgery | $133.72 | 1 | $133.72 |
| Physical Medicine & Rehabilitation | $133.72 | 1 | $133.72 |
| Surgical Oncology | $133.72 | 1 | $133.72 |
| Anesthesiology | $120.17 | 1 | $120.17 |
| Urology | $67.37 | 1 | $67.37 |
| Psychiatry | $53.80 | 1 | $53.80 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2018 |
|---|---|---|---|---|
| Dr. Martin Fuss, M.d, M.D | Radiation Oncology | Woonsocket, RI | $318,188 | $0 |
| Dr. Caley Castelein, M.d, M.D | General Practice | Miami Beach, FL | $312,353 | $0 |
| Michael Chuong, Md, MD | Radiation Oncology | Miami, FL | $123,040 | $0 |
| Percy Lee, M.d, M.D | Radiation Oncology | Irvine, CA | $55,206 | $0 |
| Drew Moghanaki, Md, MD | Radiation Oncology | Los Angeles, CA | $38,584 | $0 |
| Michael Steinberg, Md, MD | Radiation Oncology | Los Angeles, CA | $32,639 | $0 |
| Jessica Frakes | Radiation Oncology | Tampa, FL | $22,384 | $0 |
| Dr. Parag Parikh, Md, MD | Radiation Oncology | Detroit, MI | $16,677 | $0 |
| Dr. M. Salim Siddiqui, M.d., Ph.d, M.D., PH.D | Radiation Oncology | Detroit, MI | $16,650 | $0 |
| Dr. Himanshu Nagar, M.d, M.D | Radiation Oncology | New York, NY | $15,617 | $0 |
| Amar Kishan, M.d, M.D | Radiation Oncology | Los Angeles, CA | $14,632 | $0 |
| Dr. Raymond Mak, M.d, M.D | Radiation Oncology | Boston, MA | $14,478 | $0 |
| Dr. Hyun Kim, Md, MD | Radiation Oncology | Duarte, CA | $14,269 | $0 |
| Rupesh Kotecha, M.d, M.D | Radiation Oncology | Miami, FL | $14,117 | $0 |
| Dr. Mark Gold, Md, MD | Addiction Medicine | Gainesville, FL | $12,028 | $0 |
| Dr. Evan Wuthrick, M.d, M.D | Radiation Oncology | Columbus, OH | $10,648 | $0 |
| Dr. Lauren Henke, Md, MD | Radiation Oncology | Saint Louis, MO | $8,871 | $0 |
| Martin Tom, M.d, M.D | Radiation Oncology | Houston, TX | $8,400 | $0 |
| Jonathan Clark | Radiation Oncology | Durango, CO | $6,443 | $0 |
| Dr. Ann Raldow, M.d, M.D | Radiation Oncology | Los Angeles, CA | $6,300 | $0 |
| Mai Anh Huynh, Md, Phd, MD, PHD | Internal Medicine | Boston, MA | $5,891 | $0 |
| Dr. Manmeet Ahluwalia, Md, MD | Hematology & Oncology | Miami, FL | $5,800 | $0 |
| Dr. Michael Roach, Md, MD | Radiation Oncology | Honolulu, HI | $5,341 | $0 |
| Dr. Tarita Thomas, Md, Phd, MD, PHD | Radiation Oncology | Chicago, IL | $5,215 | $0 |
| Benjamin Movsas, M.d, M.D | Radiation Oncology | Detroit, MI | $5,159 | $0 |
Ad
Top Products
- MRIdian $3.3M
- MRIdian LINAC $1.8M
Associated Products (3)
- MRIdian $3.3M
- MRIdian LINAC $1.8M
- MRIDIAN $202,650
Payment Categories
- Food & Beverage $74,255
- Consulting $760,528
- Travel & Lodging $249,663
- Research $4.0M
- Royalties $130,321
About VIEWRAY TECHNOLOGIES INC
VIEWRAY TECHNOLOGIES INC has made $5.9M in payments to 304 healthcare providers, recorded across 1,509 transactions in the CMS Open Payments database. In 2022, the company paid $1.8M. The top product by payment volume is MRIdian ($3.3M).
Payments were distributed across 28 medical specialties. The top specialty by payment amount is Radiation Oncology ($849,576 to 229 doctors).
Payment categories include: Food & Beverage ($74,255), Consulting ($760,528), Research ($4.0M), Travel & Lodging ($249,663), Royalties ($130,321).
VIEWRAY TECHNOLOGIES INC is associated with 3 products in the CMS Open Payments database.